Elasmogen Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Elasmogen Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014291
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd, is a biopharmaceutical company which focuses on the development of soloMER products for the treatment of auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical candidates that derived from VNARS (variable new-antigen receptors). Elasmogen’s anti-inflammatory programmes include ELN/21 and ELN/22. It plans to provide access of soloMER generation and NDure half-life extension platforms to other organizations in partnership for the novel development of their products. The company is a spin-off from the University of Aberdeen. Elasmogen is headquartered in Aberdeen, Scotland, the UK.

Elasmogen Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Elasmogen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Elasmogen Raises Funds through Equity Financing 10
Partnerships 11
Elasmogen, Feldan Bio Enter into Agreement with Amgen 11
Feldan Bio and Elasmogen Enter into Development Partnership 12
Elasmogen and Almac Discovery Enter into Co-Development Agreement 13
Equity Offering 14
Elasmogen Spin Off from University of Aberdeen 14
Elasmogen Ltd – Key Competitors 15
Elasmogen Ltd – Key Employees 16
Elasmogen Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Mar 16, 2017: Elasmogen Receives £1.2 M In Grant And Equity Investment 18
Product News 19
Jan 20, 2017: Elasmogen – shark proteins for drug discovery 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Elasmogen Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Elasmogen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Elasmogen Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Elasmogen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Elasmogen Raises Funds through Equity Financing 10
Elasmogen, Feldan Bio Enter into Agreement with Amgen 11
Feldan Bio and Elasmogen Enter into Development Partnership 12
Elasmogen and Almac Discovery Enter into Co-Development Agreement 13
Elasmogen Spin Off from University of Aberdeen 14
Elasmogen Ltd, Key Competitors 15
Elasmogen Ltd, Key Employees 16

★海外企業調査レポート[Elasmogen Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ASV Holdings, Inc. (ASV):企業の財務・戦略的SWOT分析
    ASV Holdings, Inc. (ASV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CEZ Group:電力:M&Aディール及び事業提携情報
    Summary CEZ Group (CEZ), a subsidiary of CEZ AS, is an integrated electricity conglomerate company. The company produces and markets electricity. It generates, trades, and distributes power and heat. CEZ also provides coal mining services. The company offers services such as telecommunications, info …
  • Petroleos de Venezuela SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • Acelity Holdings, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Acelity Holdings Inc (Acelity) is a medical technology company engaged in developing wound care and regenerative medicine solutions. The company offers various solutions such as incision management, open abdomen management, epidermal harvesting and animal health. Acelity through its subsidia …
  • Universal Power Group Inc (UPGI):企業の財務・戦略的SWOT分析
    Summary Universal Power Group Inc (UPG) a subsidiary of UPGI Holdings Inc, is a provider of electric mobility products. The company through its subsidiaries supplies and distributes batteries and related power accessories. It offers sealed lead-acid batteries, ap series batteries, hc series batterie …
  • Orthofix International N.V. (OFIX):医療機器:M&Aディール及び事業提携情報
    Summary Orthofix International NV (Orthofix) is a medical device company that designs, develops, manufactures and distributes medical devices related to spine and orthopedic. Its solutions include spinal implants; human cellular and tissue based products; non-invasive regenerative stimulation produc …
  • Noor Takaful:企業の戦略・SWOT・財務分析
    Noor Takaful - Strategy, SWOT and Corporate Finance Report Summary Noor Takaful - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • KPMG International:企業の戦略・SWOT・財務分析
    KPMG International - Strategy, SWOT and Corporate Finance Report Summary KPMG International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Meiji Seika Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Meiji Seika Pharma Co Ltd (Meiji Seika Pharma), a subsidiary of Meiji Holdings Co Ltd, is a pharmaceutical solutions provider that carries out manufacturing and sale of ethical pharmaceuticals, agricultural chemicals and veterinary drugs. The company provides Streptomycin Meiji, Kanamycin Me …
  • E.Sun Financial Holding Co Ltd:企業の戦略・SWOT・財務情報
    E.Sun Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary E.Sun Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • Kirayaka Bank, Ltd.:企業の戦略・SWOT・財務情報
    Kirayaka Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kirayaka Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products portfolio includes vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects co …
  • Prysmian SpA (PRY):電力:M&Aディール及び事業提携情報
    Summary Prysmian SpA (Prysmian) is a provider of cables and systems. It designs, develops, manufactures, supplies, and installs cables for a wide range of applications. The company produces high- and medium voltage cable systems; high and extra high voltage cables; optical fiber, optical cables, opt …
  • Atkins Limited:企業のM&A・事業提携・投資動向
    Atkins Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atkins Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Elders Limited:企業の戦略・SWOT・財務情報
    Elders Limited - Strategy, SWOT and Corporate Finance Report Summary Elders Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • NuVasive Inc (NUVA)-医療機器分野:企業M&A・提携分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Kraton Polymers LLC:企業の戦略的SWOT分析
    Kraton Polymers LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Interglobe Aviation Limited:戦略・SWOT・企業財務分析
    Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆